INvolvement of breast CAncer patients during oncological consultations: a multicentre randomised controlled trial--the INCA study protocol. by Goss C. et al.
INvolvement of breast CAncer patients
during oncological consultations:
a multicentre randomised controlled
trial—the INCA study protocol
Claudia Goss,1 Alberto Ghilardi,2 Giuseppe Deledda,1 Chiara Buizza,2
Alessandro Bottacini,1 Lidia Del Piccolo,1 Michela Rimondini,1 Federica Chiodera,1
Maria Angela Mazzi,1 Mario Ballarin,1 Irene Bighelli,1 Maria Grazia Strepparava,3
Annamaria Molino,4 Elena Fiorio,4 Rolando Nortilli,5 Chiara Caliolo,5
Serena Zuliani,5 Alessandra Auriemma,5 Federica Maspero,5
Edda Lucia Simoncini,6 Fulvio Ragni,7 Richard Brown,8 Christa Zimmermann1
To cite: Goss C, Ghilardi A,
Deledda G, et al. INvolvement
of breast CAncer patients
during oncological
consultations:
a multicentre randomised
controlled trial—the INCA
study protocol. BMJ Open
2013;3:e002266.
doi:10.1136/bmjopen-2012-
002266
▸ Prepublication history for
this paper are available
online. To view these files
please visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2012-002266).
Received 25 October 2012
Revised 11 February 2013
Accepted 11 February 2013
This final article is available
for use under the terms of
the Creative Commons
Attribution Non-Commercial
2.0 Licence; see
http://bmjopen.bmj.com
For numbered affiliations see
end of article.
*Correspondence to
Dr Claudia Goss;
claudia.goss@univr.it
ABSTRACT
Introduction: Studies on patient involvement show
that physicians make few attempts to involve their
patients who ask few questions if not facilitated. On the
other hand, the patients who participate in the decision-
making process show greater treatment adherence and
have better health outcomes. Different methods to
encourage the active participation during oncological
consultation have been described; however, similar
studies in Italy are lacking. The aims of the present
study are to (1) assess the effects of a preconsultation
intervention to increase the involvement of breast
cancer patients during the consultation, and (2) explore
the role of the attending companions in the information
exchange during consultation.
Methods and analysis: All female patients with breast
cancer who attend the Oncology Out-patient Services for
the first time will provide an informed consent to
participate in the study. They are randomly assigned to
the intervention or to the control group. The intervention
consists of the presentation of a list of relevant illness-
related questions, called a question prompt sheet. The
primary outcome measure of the efficacy of the
intervention is the number of questions asked by patients
during the consultation. Secondary outcomes are the
involvement of the patient by the oncologist; the patient’s
perceived achievement of her information needs; the
patient’s satisfaction and ability to cope; the quality of the
doctor–patient relationship in terms of patient-
centeredness; and the number of questions asked by the
patient’s companions and their involvement during the
consultation. All outcome measures are supposed to
significantly increase in the intervention group.
Ethics and dissemination: The study was approved
by the local Ethics Committee of the Hospital Trust of
Verona. Study findings will be disseminated through
peer-reviewed publications and conference presentations.
Trial registration: ClinicalTrials.gov identifier:
NCT01510964
ARTICLE SUMMARY
Article focus
▪ This article assesses if a preconsultation inter-
vention (QPS) facilitates greater participation of
patients in the consultation process, by deter-
mining an increase in questioning and/or in the
number of different illness related issues (eg,
diagnosis, treatment, prognosis) being discussed
with the oncologist.
▪ This article assesses the effect of the QPS on the
level of patient involvement by the oncologists,
on patient satisfaction and coping, on the oncol-
ogist’s perception of patient’s preferred decisio-
nal role and to explore the role of the
companion.
Key messages
▪ The involvement and participation of patients in
therapeutic programmes are of great interest to
not only physicians but also all health profes-
sionals engaged in improving patients’ adherence
to treatment regimens or operating in the field of
health promotion.
▪ We expect that patients who have the opportun-
ity to rehearse their information needs before the
consultation will ask a greater number of ques-
tions which in turn will determine their greater
involvement by the physician and a greater
number of satisfied needs.
▪ We also expect that the straightforward use of
a list of printed questions of potential rele-
vance for cancer patients and their compa-
nions at an early stage of illness, by modifying
the process of information exchange, will
increase their participation and satisfaction
with the consultation, with potential benefits
for treatment adherence and consequently
treatment efficacy.
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INTRODUCTION
In recent years, the interest in communication issues in
cancer care has steadily increased, in particular regard-
ing the information needs of oncology patients, the
communication of bad news and the impact of such
news on patients, and the development of guidelines on
how clinicians can deliver bad news in a sensitive way.1 2
Research evidence suggests that patients have varying
preferences for the amount and type of information
they desire.3 Good clinical practice entails oncologists
recognising these variations in patient preferences, and
physicians and patients working together to accomplish
these preferences. In order to accommodate these
varying preferences, the physicians need to elicit patient
preferences and to adapt their information giving pro-
cesses to meet these needs. If the expression of such
needs is not facilitated or encouraged, these needs tend
to remain hidden; consequently, the patients may per-
ceive that they received too much or too little informa-
tion. The literature suggests that a better quality of
patient care and patient outcomes such as coping with
illness and treatment adherence are achieved when pre-
ferences are met.4 How the physician conducts the inter-
view and gives information5 has a direct effect on the
participation of the patient. It has been observed that
what the physician says has an immediate effect on what
the patients says, and therefore can also inﬂuence the
degree of patient participation in the consultation.6 7
One proven method to encourage patients to be more
active communicators is to provide question prompt
sheets (QPS).8–16 QPS are structured lists of prepared
questions that prompt patients to consider novel topics
before a consultation and decide on the question they
would like to ask during the consultation. These tools
have been shown to increase patient activation during
consultation and aid the recall of information after con-
sultation. Although QPS have been shown to be helpful,
there is a need to replicate these studies in different cul-
tural contexts in order to test the feasibility of such aids
and to support the ﬁndings.
In Italy, during the medical consultation, the patients
are frequently accompanied and assisted by a
companion: a close family member or another key
person. In this context, the activation and involvement
of the patient interact with that of the companion’s and
contribute to the communication dynamics of the con-
sultation. Ohlen et al17 explored the importance of sig-
niﬁcant others in therapeutic decisions and highlighted
the notion of ‘relational autonomy’, which acknowledges
that people are deﬁned by their relationships and are
dependent on others in making decisions.18 Future
research that analyses patients and their companions as
dyadic units would offer further insight into the impact
of social relations on the treatment decision-making pro-
cesses. More evidence on the information needs of the
companions regarding the patient and their role in the
information and decision-making processes during the
consultation is also needed.
To our knowledge, this is the ﬁrst randomised con-
trolled trial in Europe which assesses the effects of a pre-
consultation intervention (QPS) on the cancer patients’
involvement during the consultation, on their satisfac-
tion and conﬁdence in coping with illness and which
explores the role of the companion during the
consultation.
METHODS AND ANALYSIS
Study design
This is a multicentre, randomised controlled trial in
which the patients are attributed randomly to the inter-
vention or to the control group on a 1:1 basis. The
patients in the intervention group are given the QPS, a
list of 50 speciﬁc questions (see below); those in the
control group are given a control sheet on which to
write the questions they would like to ask. The oncolo-
gists are informed about the study protocol, but are
blinded to whether the patient is a participant of the
control group or the intervention group. The oncolo-
gists perform their consultation as usual according to
the clinical practice of their centre. After concluding the
consultation, they complete two questionnaires
(DPRQ-10 and Control Preference Scale (CPS), see the
Measures section for details) regarding the patient and
the consultation.
This protocol follows the CONSORT guidelines.19
Standardised questionnaires are administered at base-
line (before the randomisation) and immediately after
the consultation (ﬁgure 1, table 1).
The time required to answer the preconsultation ques-
tionnaire is approximately 15–20 min, while the post-
consultation questionnaire takes between 10 and 15 min
to complete.
Intervention
The patients and their companions (if present) of both,
intervention and control group, receive a form on which
they were asked to write their reply to the following
request: ‘Please indicate the issues which you want to
discuss today with your oncologist’.
ARTICLE SUMMARY
Strengths and limitations of this study
▪ To our knowledge, this is the first randomised controlled trial
in Europe which assesses the effects of QPS on cancer
patients’ involvement during the consultation, on their satisfac-
tion and confidence in coping with illness and which explores
the role of the companion during the consultation.
▪ QPS in this study is administered before the consultation and
collected by the researcher and not available to the patient
during the consultation. Thus, patients may not remember
their questions selected on the QPS and undermine the
hypothesis of the greater participation of the QPS intervention
group.
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The patients and their companions (if present) rando-
mised to the intervention group receive the QPS in add-
ition to the form described above. An introduction
explains the importance of asking questions during the
consultations. The patients (and their companions) are
invited to select and circle the salient questions, if any,
from the 50 questions included in the QPS. These ques-
tions have been chosen and adapted on the basis of pre-
vious studies in the ﬁeld8–16 and are divided by topics.
The questions were regarding diagnosis (eg, ‘Of what
type is my cancer?’), treatment (eg, ‘What are the advan-
tages and disadvantages of the treatment?’), contribu-
tion of the patient and lifestyle (‘What can I do to
improve the efﬁcacy of treatment?’), prognosis (‘What
are the chances of relapse?’) and other issues (eg, ‘Do I
need a referral from my GP for the next visit?’).
Setting
The patient recruitment phase of this protocol has
begun at three oncology departments in Northern Italy:
Figure 1 INCA study flow diagram.
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two run by the Hospital Trust of Verona in the Veneto
region (placed in two different part of the city) and one
by the Hospital Trust of Brescia in the Lombardia
region. The recruitment phase started in June 2011 and
will continue for 2 years or until the sample size has
been reached.
The population of Verona city and its province in 2010
was about 914 382, and the population of Brescia city
and its province about 1 242 923.20 In the Veneto
region, the estimation of the incidence of breast cancer
in 2010 was 4424 new cases per year (standardised rate
adjusted for age using the European population as
standard (std) per 100 000=133). In the Lombardia
region, the estimation of the incidence of breast cancer
in 2010 was 7456 new cases per year (std=109).21
The three oncology departments each have outpatient
clinics dedicated to patients with breast cancer with a
rotation of 2–5 oncologists. New medical oncology
patient appointments are scheduled on ﬁxed days with a
number of 4–8 patients per day. Generally, in the ﬁrst
Table 1 Questionnaires and tools used in the study
Tool Evaluation Explored area Items (n) Time
State-Trait Anxiety Inventory—X1
(STAI-X1)
Patient and
companion
State anxiety level 20 Before the
consultation
Patient Health Questionnaire—9
(PHQ-9)
Patient and
companion
Depression 9 Before
General Health Questionnaire—12
(GHQ-12)
Patient and
companion
Psychological distress 12 Before
Decision Self Efficacy Scale (DSES*) Patient and
companion
Confidence with decision 11 Before
Control Preference Scale (CPS) Patient and
companion
Role in the decision making
process
5 vignettes
Participant chooses the one
preferred
Before
Eysenck Personality Questionnaire—
Reduced form (EPQ-R)
Patient and
companion
Personality traits 24 Before
Doctor-Patient Scale (DP) Oncologists Oncologists’ communication
style
48 One time only
Patient Enablement Instrument Patient and
companion
Ability to cope with illness 6 After the
consultation
Shared Decision Making
Questionnaire (SDMQ*)
Patient and
companion
Patient involvement 9 After
Satisfaction With Decision scale
(SWD*)
Patient and
companion
Satisfaction with decision 6 After
Patient–Doctor Relationship
Questionnaire—9 (PDRQ-9*)
Patient and
companion
Doctor–patient relationship 9 After
Recall questionnaire (RECALL*) Patient and
companion
Recalling and
understanding of
information
10 After
State-Trait Anxiety Inventory—X1/
Reduced form (STAI-X1/R)
Patient and
companion
State anxiety level 10 After
Difficult Doctor-Patient Relationship
Questionnaire (DDPRQ-10)
Oncologists Difficulties in relationship
with the patient
12 After
Control Preference Scale (CPS) Oncologists Patient’s role in the decision
making process
5 vignettes
Oncologist chooses the one
supposingly preferred by the patient
After
AUDIORECORDING Consultation Interaction between doctor
and patient
– –
Observing Patient Involvement in
Decision Making scale (OPTION)
External rater Professional behaviours
intended to involve patients
12 –
Verona Patient-centred
Communication Evaluation scale
(VR-COPE)
External rater Aspects of patient-centred
communication
9 –
Assessing Interpersonal Motivations
in Transcripts (AIMIT)
External rater Activity of interpersonal
motivational systems
Coding system
applied on
transcripts
–
*Adapted version for companion.
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visit with the oncologist, the histological results are com-
municated and further medical treatment is decided
(eg, chemotherapy, hormone therapy). The length of
the visit can vary from 30 to 60 min.
Sample and recruitment
The study sample is composed of consecutive female
patients between the age of 18 and 75 years who attend
the oncology outpatient clinics at the participating
centres and have a recent diagnosis of breast cancer at
an early stage (absence of metastasis). Eligible patients
have already undergone breast surgery (eg, lumpec-
tomy). Exclusion criteria are the presence of metastasis
or relapse, severe mental deterioration and comprehen-
sion difﬁculties of the Italian language. A sample of 300
patients will be recruited, as estimated by the sample
size calculation (see below).
Procedure
Before the patient recruitment phase, the oncologists
were informed about the study and invited to partici-
pate. The willing oncologist provided written informed
consent.
Eligible patients attending their ﬁrst outpatient visit
with the oncologist (and their companions if present)
are provided with the information about the study by a
project member who is available to answer any ques-
tions. The willing patients provide written informed
consent to participate in the study (ﬁgure 1).
Once consented, the patients and their companions
receive an envelope containing six questionnaires to
answer before the consultation (baseline assessment,
table 1). The project staff member (MAM) then ran-
domly allocates consenting patients and their compa-
nions to the intervention or control group (see also
paragraph ‘Randomisation’). Another project staff
member (AB, CB, IB or FC) hands out the envelopes
with either the intervention QPS or the control sheet and
collect the sheets after their completion. In order to keep
the oncologists blind to the intervention or control
status, patients do not take the QPS into the consultation.
The subsequent consultation is audio-recorded. After
the consultation, patients and their companions com-
plete further six questionnaires. In the event that a
patient or the companion is distressed after the consult-
ation, a trained project member present (AB, CB, IB or
FC) will provide support.
At the completion of the consultation, the oncologists
ﬁll the medical details sheet that asks about the cancer
stage and type, when and by whom the patient was
informed about the diagnosis and the therapeutic
options appropriate for this patient. They also complete
a questionnaire measuring their perception of the
patient as difﬁcult.
The audio tapes and oncologists’ forms are collected
by the project staff.
The audio tapes are examined for the content and
number of questions asked by patients and companions,
and are rated applying the OPTION scale,22–24 which
measures the extent to which the oncologist has suc-
ceeded to involve the patient in the consultation. The
questions that emerge during the consultations are com-
pared with those expressed before the visit. The audio-
recorded consultations are also analysed in terms of
patient-centredness with the VR-COPE25 and with the
Assessment of Interpersonal Motivation in Transcripts
(AIMIT)26 which evaluates the ﬁve different motiv-
ational systems that guide the verbal and non-verbal
behaviours during interactions.
Randomisation
The randomisation sequence is conducted off-site using
the ‘random allocation of treatments balanced in blocks
(ralloc)’ package for Stata27 and is stratiﬁed by centre
with a 1:1 allocation ratio of treatment. Block randomisa-
tion (size 4) is used to minimise large imbalances
between the intervention groups. The allocation
sequences are generated by an independent individual,
are stored in computer ﬁles and remain unknown to the
researchers until the patient is randomised.
The QPS or the control sheet, chosen for the two
arms of trial, are placed in opaque envelopes, sealed
and numbered in sequence (following the list generated
by the randomisation procedure) by a staff member of
each centre (MAM and CB), not involved in the data
collection phase. Both randomisation procedure and
treatment allocation have been developed to fully
conceal the treatment allocation.19 28
The patients and the oncologists are unaware of the
allocation. The raters who analyse the audio recordings
are also blinded to the allocation of patients.
Study aims and hypotheses
The main aim is to assess if a preconsultation interven-
tion (QPS) facilitates greater participation of patients in
the consultation process, by determining an increase in
questioning and/or in the number of different illness
related issues (eg, diagnosis, treatment, prognosis) being
discussed with the oncologist.
Other aims are to assess the effect of the QPS on the
level of patient involvement by the oncologists, on
patient satisfaction and coping, on the oncologist’s per-
ception of patient’s preferred decisional role (using the
CPS, more details see the measures section) and to
explore the role of the companion.
In detail, the study investigates if the intervention
determines
▸ A greater number of personal information needs
expressed during the consultation (the number and
type of the questions asked during the consultation);
▸ The perception of a greater capacity to cope with
illness and a greater satisfaction with decisions made
during the consultation (measured with the Patient
Enablement Instrument (PEI) and Satisfaction with
Decision Scale (SWD); details are described in the
Measures section);
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▸ Greater patient-generated and/or doctor-generated
involvement of the patient (using the OPTION scale
and SDM-Q; details are described in the Measures
section);
▸ A better understanding of the received information
and greater satisfaction (measured with the Recall
questionnaire and the SWD);
▸ A more accurate identiﬁcation by the oncologist of
patients’ preferred role in the therapeutic decisions
(measured with the CPS answered by the oncologist;
details are described in the Measures section);
▸ A more supportive doctor–patient relationship per-
ceived by the oncologist and the patient (using the
PDRQ-9 and DDPRQ-10, see Measures section for the
details);
▸ A more patient-centred and sharing approach during
the consultation (using the VR-COPE and the AIMIT;
see Measures section for the details).
Extending the QPS to the patient’s companion (if
present) allows us to explore the impact of the QPS on
the companions’ role and participation during the con-
sultation. The number and type of questions asked by
the companion during the consultation are recorded.
The companions answer the same questionnaires as the
patient—PEI for the evaluation of the ability to cope
with the patients’ illness, SDM-Q for the evaluation the
perceived involvement during the consultation, SWD for
the satisfaction with decision, PDRQ-9 for the doctor–
patient relationship and Recall Questionnaire for the
understanding of the information received. Where
necessary, questionnaires were adapted to the compa-
nions by substituting the ﬁrst person (I) used in the
patient version, with the third person (she). For
example: ‘I feel conﬁdent that I can get the facts about
the medication choices available to her’ instead of ‘I feel
conﬁdent that I can get the facts about the medication
choices available to me’ (item 1 of the DSES Scale).
Study measures
Sociodemographic and clinical data
Sociodemographic data collected from patients are age,
education, family status and employment status, type of
relationship with the companion (if present), reported
both by the patients and their companions during the
baseline assessment.
Oncologists’ sociodemographic data are age, gender
and years of experience. Data for oncology residents
(when present during the consultation) are also
obtained.
Clinical data are cancer stage and type, duration of
illness (who has informed patient on diagnosis and
when) and therapeutic options considered appropriate
for this patient, all reported on a form by the oncologist.
Primary outcome measure
The primary outcome measure of this study is the
number of patient’s questions during the consultation
regarding diagnosis, prognosis, treatment, lifestyle and
other issues. Question asking is considered an index of
the patient’s participation during the consultation. The
QPS aims to increase the number of questions by giving
the opportunity to patients to reﬂect on their inform-
ative needs choosing among a wide range of possible
questions those which are perceived as most relevant in
view of the subsequent consultation. We hypothesise that
patients who are randomised to receive the QPS will ask
more questions than the patients randomised to the
control group.
Secondary outcome measures
The secondary outcome measures are the following:
▸ The number of unmet information needs obtained
by comparing the number of questions indicated by
patients and their companion before the consultation
(ie, those selected in the QPS by patient) with those
actually raised during the consultation (ie, those iden-
tiﬁed subsequent to listening to the audio
recordings).
▸ Ability to cope with the illness, measured with the
PEI. This questionnaire is a self-administered ques-
tionnaire of six items on a Likert scale from 0 (same
or less) to two (much better, much more).29 We
hypothesise that patients randomised to the interven-
tion group will have higher ‘coping with illness’
scores compared to patients in the control group.
▸ Patient involvement, measured with the Shared
Decision Making Questionnaire (SDM-Q) and the
OPTION Scale. The SDM-Q is a self-administered
questionnaire of nine items on a Likert scale from 1
(completely disagree) to 6 (agree completely) that
assesses patients’ perception of the decisional process
and their level of involvement during the consult-
ation, the information received on therapeutic
options, potential risks and beneﬁts regarding the
participation at the decisional process.30 31 The
OPTION Scale is composed of 12 items of oper-
ational deﬁnitions of different patient-involving skills,
rated on a Likert scale from 0 (behaviour absent) to 4
(behaviour observed at an excellent skill level).22–24
The scale is applied by trained raters to the audio
recording of the consultation. In summary, it exam-
ines whether problems are well-deﬁned, whether
options are formulated, information provided, patient
understanding and role preference evaluated, and
decisions examined from both the professional and
patient perspective. The total score ranges from 0 (0
in all items) to 48 (4 in all items) and is transformed
into a 0–100 score. We hypothesise that patients ran-
domised to the intervention group will have higher
patient involvement during the consultation com-
pared to patients in the control group.
▸ Satisfaction with decisions made during the consult-
ation, measured with the SWD. This is a self-report
questionnaire of six items on a Likert scale from 0
(completely disagree) to 5 (agree completely).32 We
hypothesise that patients randomised to the
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intervention group will have higher patient satisfac-
tion compared to patients in the control group.
▸ Recalling and understanding of information, mea-
sured with the Recall Questionnaire. This question-
naire consists of six items that ask the patient to recall
the received information on treatment decisions and
pathology (eg, ‘What was the treatment decision?
Which treatment options were discussed?’). The ques-
tions have been prepared for the present study with
reference to previous studies.11 33 34 The question-
naire enables an evaluation of the accuracy of
patient’s recall and understanding of information
delivered during the consultation by comparing the
patients’ answers with the contents of the actual con-
sultation discussion gathered from the consultation
audiorecording. We hypothesise that patients rando-
mised to the intervention group will recall more
precise information compared to patients in the
control group.
▸ Three other questions, rated on a 0 (no at all) to 5
(very much) Likert scale asked whether the patient
asked their selected QPS questions, whether the
oncologist answered the questions and whether the
patient received the information they desired. We
hypothesise that patients randomised to the interven-
tion group will feel themselves more successful in
question asking. compared to patients in the control
group.
▸ Overall consultation atmosphere, is measured with
the Verona Patient-centred Communication
Evaluation scale (VR-COPE) and the Assessing
Interpersonal Motivations in Transcripts (AIMIT).
The VR-COPE25 assesses the content, the process and
relational aspects of patient-centred communication
during medical consultations on the basis of a multi-
dimensional evaluation and comprises nine items.
Each item is deﬁned by operational deﬁnitions and
rated on a 0–10 point scale. The scale is applied by
trained raters to the consultation audiorecordings.
We expect that patients of the intervention group
establish a better relationship with their oncologist
and show higher scores in patient-centred communi-
cation. The AIMIT26 is a coding system applied to
transcripts that systematically detects the activity of
ﬁve interpersonal motivational systems (attachment,
caregiving, rank, sexuality and cooperation). We
hypothesise that patients randomised to the interven-
tion group will more often evidence a cooperative
style during the consultation compared to patients in
the control group.
▸ Perceived Patient–doctor relationship, measured with
the Patient–Doctor Relationship Questionnaire
(PDRQ-9) and the Difﬁcult Doctor Patient
Relationship Questionnaire (DDPRQ-10). The
PDRQ-9 contains nine items on a Likert scale with
anchors at 1 (not at all appropriate) to 5 (totally
appropriate). The scale measures patient perceptions
of their relationship with the doctor.25 The
DDPRQ-10 contains 10 items on a Likert scale
anchors at 1 (not at all) to 6 (a great deal) and is
completed by physicians after the encounter with a
patient.36 37 The questionnaire identiﬁes the patients
experienced as difﬁcult patients. We hypothesise that
the doctor–patient relationship in the intervention
group is perceived as less difﬁcult compared to the
control group.
▸ Oncologists answered three questions on the poten-
tial presence of anxiety, depression or emotional dis-
tress in the patient and a fourth on their difﬁculty
experienced in answering the patient’s questions. We
hypothesise that answering questions of patients in
the intervention group will be perceived by oncolo-
gists as less difﬁcult.
▸ Perceived role preference of the patient, measured
with the CPS, Oncologist version.38 39 This scale
assesses how the oncologist perceives the role that
patient might prefer regarding the decision making
process. Oncologists should be better able to identify
patients preferred role in the intervention group.
▸ Duration of the consultation, measured in minutes.
We hypothesise a longer duration of the consultation
in the intervention group compared to the control
group.
Process-related and potential confounding variables
The measures below have been collected in order to
check their possible inﬂuence on question asking
(primary outcome).
▸ Anxiety, depression and general well-being, measured
with the State Anxiety Inventory (STAI-X1, XR),40–42
the Patient Health Questionnaire depression scale
(PHQ-9)43–45 and the General Health Questionnaire
(GHQ-12).46 STAI-X1 is a self-administered question-
naire of 20 items on a Likert scale from 1 (not at all) to
4 (very much) completed before the consultation.
Higher total scores indicate greater state anxiety. The
STAI-X1R, administered after the consultation, is a
shorter version of 10 out of the 20 items of the
STAI-X1, and it is used to evaluate the state anxiety level
at the end of the consultation and to compare this level
with the one measured at the beginning. PHQ-9 is a
self-assessment questionnaire for detecting the pres-
ence of depression and consists of nine items with
response options of 0 (not at all) to 3 (almost every
day), and has a summative score range of 0 to 27. We
score it in the standard way, using the sum of the 0–3
scores for each item, and ≥8 as a cut-off score for pos-
sible cases of depression.43–45 GHQ-12 is a self-
administrated questionnaire of 12 items and has a sum-
mative score range of 0 to 12 and a cut-off score of >3
indicating psychological distress.46
▸ Personality traits, measured with the Eysenck
Personality Questionnaire (EPQR-S).47 The EPQR-S is
a self-administered questionnaire of 48 items on
yes/no scale. For our study, we use two subscales:
the Extroversion/Introversion (12 items) and
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Neuroticism/Stability (12 items). The ‘Extroversion’
is characterised by being outgoing, talkative, high on
positive affect (feeling good) and in need of external
stimulation. The ‘Neuroticism’ or emotionality is
characterised by high levels of negative effect such as
depression and anxiety.
▸ Conﬁdence with decision, measured with the
Decision Self Efﬁcacy Scale (DSES).48 This self-
administered questionnaire for patients consists of 11
items on a Likert scale from 0 (not at all conﬁdent)
to 4 (very conﬁdent).
▸ Patients’ and their companion’s preference for the
role they want to have in the decision-making process,
measured with the CPS.38 39 This self-administered
instrument contains ﬁve vignettes with text, depicting
different patient roles (from active to passive) from
which patients choose the one considered as most
appropriate for them.
▸ Patient-centred communication style and attitude
toward the doctor–patient relationship, measured
with the Doctor–Patient (DP) Scale.49 The Scale mea-
sures the degree of oncologists’ self-reported patient
or doctor-centred communication style and attitude.
It consists of 48 statements to rate on a Likert scale
from 1 (strong agreement) to 5 (strong disagree-
ment). It has a summative score range of 48–240. The
scale is completed by all oncologists who join the
study.
Sample size calculation
A sample of 300 patients will be recruited. This number
has been estimated to account for approximately 15% of
withdrawal rate, so that 250–260 patients will complete
the study, with about 130 patients in each arm. The
primary outcome measure is the number of patient
questions. The international literature reports a mean
number of nine questions (range 0–53) for patients with
breast cancer patients. Since such data are not available
in the Italian context, an observational phase was con-
ducted. We recruited a sample of 30 patients (10 for
each centre) with the same characteristics, in order to
assess the number and type of questions asked by the
patient during the consultation, to understand the
ongoing interaction between oncologists and patients in
a ﬁrst encounter and to test the feasibility of procedures
and questionnaires. This observational study resulted in
a mean number of 18 (sd=13) patient questions asked
during a ﬁrst encounter with the oncologist; no signiﬁ-
cant difference was found between the three centres
(median test: χ2=2.4, p=0.30).
An intervention intended to increase the number of
questions might be considered efﬁcacious with an
increase of 30%. The sample size required to evidence
such difference was calculated using the sampsi
command of Stata 11,50 assuming a power of 80% and a
two-sided signiﬁcant level of 5% on a Student t test for
differences between independent groups.51 52
Statistical analysis
The data will be analysed according to intention-to-treat
principle.53 Standard statistical techniques will be used
to describe the characteristics of patients in both groups,
and CONSORT ﬂow diagram will be shown in order to
explain the phases of trial and inform on the ﬁndings
conﬁdence.19 The primary outcome, signiﬁcant increase
of patient questions, will be compared in the two arms
using t test. If adjustment for possible baseline differ-
ences among patients (as well as for oncologists and
centres) is needed, an analysis of covariance will be
done. Regarding secondary outcome measures, multi-
level analyses will be used to taking into account the spe-
ciﬁc effect of the individual oncologist.53
EXPECTED ACHIEVEMENT
The involvement and participation of patients in thera-
peutic programmes is of great interest to not only physi-
cians but also all health professionals engaged in
improving patients’ adherence to treatment regimens or
operating in the ﬁeld of health promotion.
We expect that patients who have the opportunity to
rehearse their information needs before the consult-
ation will ask a greater number of questions and we will
observe higher levels of involvement by the physician
and a higher number of met information needs. The
use of a simple question prompt sheet may improve
the overall communication between the oncologist and
the patient. This intervention will be easy to disseminate
and use in routine clinical practice to increase patient
and companion participation.
DISCUSSION
It has been demonstrated in English-speaking countries
that a QPS is a useful tool to improve the patient’s par-
ticipation during the consultation. However, we contend
that consultation communication may vary across cul-
tures and thus there is a need to explore the efﬁcacy of
a QPS in non-English speaking countries to explore
cross-cultural differences. To our knowledge, there are
no published randomised controlled trials in Europe
that assess the effects of a preconsultation QPS on
patient and companion communication. The study has a
strong design that incorporates computerised random
allocation, blinding of data-collection staff and the use
of audio recording as an objective measure of consult-
ation communication. The analysis of the consultation
recordings is a valuable research method and is a recom-
mended tool for documenting the interaction between
patients and oncologists.55
There are some limitations to consider. The QPS is
not being used prior to the consultation, while, in previ-
ous trials reported in literature,8–16 patients take the
QPS into the consultation to serve as a reminder to ask
questions. We selected this study method to ensure that
participating oncologists are (a) kept blind to the
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intervention or control status of the patients and (b) not
forced to change their routine clinical practice.
The ﬁndings from this study will provide a basis for
further research in the ﬁeld and provide potentially
important results for clinicians, patients and policy
makers that may lead to a wider use of the QPS.
ETHICS AND DISSEMINATION PLANS
The study was approved by the local Ethics Committees
of the Hospital Trust of Verona. The study is registered
at ClincialTrial.gov (identiﬁer: NCT01510964). This
protocol follows the CONSORT guidelines.19
Recruitment phase started in June 2011 and will con-
tinue till the enrolment will be completed and is
expected to be closed in May 2013. Analysis will start
after data monitoring and checking is completed. The
dissemination of the trial ﬁndings will principally be
carried out through publications in peer-review journal
and presentations at national/international conferences
focused on cancer and/or communication, for examples
European Association for Communication in Health
Care Conferences and International Shared Decision
Making Conferences.
Author affiliations
1Department of Public Health and Community Medicine, Section of Clinical
Psychology, University of Verona, Verona, Italy
2Department of Childcare and Biomedical Technologies, Section of Clinical
and Dynamic Psychology, Faculty of Medicine and Surgery, University of
Brescia, Brescia, Italy
3Department of Experimental Medicine, Section of Clinical Psychology, Faculty
of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy
4Oncology Unit of Oncology, Ospedale Civile Maggiore, Hospital Trust of
Verona, Verona, Italy
5Oncology Unit of Oncology, Policlinico G. Rossi, Hospital Trust of Verona,
Verona, Italy
6Medical Oncology, Spedali Civili, Brescia, Italy
7General Surgery II, Spedali Civili, Brescia, Italy
8Department of Social and Behavioral Health, School of Medicine, Virginia
Commonwealth University, Richmond, Virginia, USA
Contribuors CG, LDP, MR and CZ developed the study protocol and together
with AG and MGS supervised the all procedures. MAM is the trial statistician
and is responsible for generating the randomisation sequences and providing
guidance on statistical analysis of trial data. MB is the computer scientist who
developed the database to save the data. CG drafted the manuscript in
collaboration with RB. CG will oversee enrolment and data collection. GD, AB,
FC, CB, IB, AM, EF, RN, CC, SZ, AA, FM, ELS and FR participated in enrolling
the patients. All authors saw and approved the final version of the manuscript.
Funding This research received no specific grant from any funding agency in
the public, commercial or not-for-profit sectors.
Competing interests None.
Ethics approval Local Ethics Committee of the Hospital Trust of Verona, Italy.
Provenance and peer review Not commissioned; externally peer reviewed.
REFERENCES
1. Buckman R. Breaking bad news: a guide for healthcare
professionals. Baltimore, MD: John Hopkins University Press, 1992.
2. Baile WF, Buckman R, Lenzi R, et al. AP. SPIKES—a six-step
protocol for delivering bad news: application to the patient with
cancer. Oncologist 2000;5:302–11.
3. Jefford M, Tattersall MH. Informing and involving cancer patients in
their own care. Lancet Oncol 2002;3:629–37.
4. Joosten EAG, DeFuentes-Merilla L, de Weert GH, et al. Systematic
review of the effects of shared decision making on patient
satisfaction, treatment adherence and health status. Psychother
Psychosom 2008;77:219–26.
5. Charles C, Gafni A, Whelan T. How to improve communication
between doctors and patients. Learning more about the decision
making context is important. BMJ 2000;320:1220–1.
6. Drew P, Chatwin J, Collins S. Conversation analysis: a method for
research into interactions between patients and health-care
professionals. Health Expect 2001;4:58–70.
7. Zimmermann C, Del Piccolo L, Mazzi MA. Patient cues and medical
interviewing in general practice. Examples of the application of
sequential analysis. Epidemiol Psychiatr Soc 2003;12:115–23.
8. Clayton JM, Butow PN, Tattersall MH, et al. Randomized controlled
trial of a prompt list to help advanced cancer patients and their
caregivers to ask questions about prognosis and end-of-life care. J
Clin Oncol 2007;25:715–23.
9. Butow PN, Dunn SM, Tattersall MHN,, et al. Patient participation in
the cancer consultation: evaluation of a question prompt sheet. Ann
Oncol 1994;5:199–204.
10. Brown R, Butow PN, Boyer MJ, et al. Promoting patient participation
in the cancer consultation: evaluation of a prompt sheet and
coaching in question-asking. Br J Cancer 1999;80:242–8.
11. Brown RF, Butow PN, Dunn SM, et al. Promoting patient
participation and shortening cancer consultations: a randomised trial.
Br J Cancer 2001;8:1273–9.
12. Bruera E, Sweeney C, Willey J, et al. Breast cancer patient
perception of the helpfulness of a prompt sheet versus a general
information sheet during outpatient consultation: a randomized
controlled trial. J Pain Symptom Manage 2003;5:412–19.
13. Glynne-Jones R, Ostler P, Lumley-Graybow S, et al. Can I look at
my list? An evaluation of a ‘prompt sheet’ within an oncology
outpatient clinic. Clin Oncol 2006;18:395–400.
14. Clayton J, Butow P, Tattersall M, et al. Asking questions can help:
development and preliminary evaluation of a question prompt list for
palliative care patients. Br J Cancer 2003;89:2069–77.
15. Van der Meulen N, Jansen J, van Dulmen S, et al. Interventions to
improve recall of medical information in cancer patients: a systematic
review of the literature. Psychooncology 2008;17:857–68.
16. Van Weert JC, Jansen J, Spreeuwenberg PM, et al. Effects of
communication skills training and a question prompt sheet to
improve communication with older cancer patients: a randomized
controlled trial. Crit Rev Oncol Hematol 2011;80:145–59.
17. Ohlen J, Balneaves L, Bottorff J, et al. The influence of significant
others in complementary and alternative medicine decisions by
cancer patients. Soc Sci Med 2006;63:1625–36.
18. Christman J. Relational autonomy, liberal individualism, and the
social constitution of selves. Philos Stud 2004;117:143–64.
19. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010
explanation and elaboration: updated guidelines for reporting parallel
group randomized trials. BMJ 2010;340:c869.
20. Istituto Nazionale di Statistica (ISTAT) Web site. http://www.demo.
istat.it/pop2010/index.html (accessed 24 Oct 2012).
21. Centro Nazionale di Epidemiologia, Sorveglianza e Promozione
della Salute—Istituto Superiore di Sanità (ISS) Web site. http://www.
tumori.net/it3/banca_dati/query.php (accessed 24 Oct 2012).
22. Elwyn G, Hutchings H, Edwards A, et al. The OPTION scale:
measuring the extent that clinicians involve patients in
decision-making tasks. Health Expect 2005;8:34–42.
23. Goss C, Fontanesi S, Mazzi MA, et al. The assessment of patient
involvement across consultation. The Italian version of the OPTION
scale (in Italian). Epidemiol Psichiatr Soc 2007;16:339–49.
24. Goss C, Fontanesi S, Mazzi MA, et al. Shared decision making: the
reliability of the OPTION scale in Italy. Patient Educ Couns
2007;66:296–302.
25. Del Piccolo L, Mazzi MA, Scardoni S, et al. A theory based proposal
to evaluate patient-centred communication in medical consultations:
the Verona Patient-centred Communication Evaluation scale
(VR-COPE). Health Educ 2008;108:355–72.
26. Fassone G, Valcella F, Pallini S, et al. Assessment of Interpersonal
Motivation in Transcripts (AIMIT): an inter- and intra-rater reliability
study of a new method of detection of interpersonal motivational
systems in psychotherapy. Clin Psychol Psychother
2012;19:224–34.
27. Ryan P. sxd1 4: Random allocation of treatments in blocks. Stata J
2008;8:146.
28. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT
statement for reporting randomized trials: explanation and
elaboration. Ann Intern Med 2001;134:663–94.
Goss C, Ghilardi A, Deledda G, et al. BMJ Open 2013;3:e002266. doi:10.1136/bmjopen-2012-002266 9
The INCA study protocol
 group.bmj.com on September 11, 2013 - Published by bmjopen.bmj.comDownloaded from 
29. Howie JG, Heaney DJ, Maxwell M, et al. A comparison of a Patient
Enablement Instrument (PEI) against two established satisfaction
scales as an outcome measure of primary care consultations. Fam
Pract 1998;15:165–71.
30. Simon D, Chorr G, Wirtz M, et al. Development and first validation of
the shared decision making questionnaire (SDM-Q). Patient Educ
Couns 2006;63:319–27.
31. Kriston L, Scholl I, Hölzel L, et al. The 9-item Shared Decision Making
Questionnaire (SDM-Q-9). Development and psychometric properties
in a primary care sample. Patient Educ Couns 2010;80:94–9.
32. Holmes-Rovner M, Kroll J, Schmitt N, et al. Patient satisfaction with
health care decisions: the Satisfaction with Decision Scale. Med
Decis Making 1996;16:58–64.
33. Gattellari M, Voigt KJ, Butow PN, et al. When the treatment goal is
not cure: are cancer patients equipped to make informed decisions?
J Clin Oncol 2002;20:503–13.
34. Whelan T, Levine M, Gafni A, et al. Mastectomy or lumpectomy?
Helping women make informed choices. J Clin Oncol
1999;17:1727–35.
35. Van der Feltz-Cornelis CM, Van Oppen P, Van Marwijk HWJ, et al.
A patient-doctor relationship questionnaire (PDRQ-9) in primary
care: development and psychometric evaluation. Gen Hosp
Psychiatry 2004;26:115–20.
36. Hahn SR, Thompson KS, Wills TA, et al. The difficult doctor-patient
relationship: somatization, personality and psychopathology. J Clin
Epidemiol 1994;47:647–57.
37. Hahn SR, Kroenke K, Spitzer RL, et al. The difficult patient:
prevalence, psychopathology, and functional impairment. J Gen
Intern Med 1996;11:1–8.
38. Degner LF, Sloan JA, Venkatesh P. The control preferences scale.
Can J Nurs Res 1997;29:21–43.
39. Giordano A, Mattarozzi K, Pucci E, et al. Participation in medical
decision-making: attitudes of Italians with multiple sclerosis. J Neurol
Sci 2008;275:86–91.
40. Spielberger CD. Anxiety as an emotional state. Vol. 1. New York:
Academic Press, 1972.
41. Spielberger CD, Gorsuch RL, Lushene R, et al. Manual for the
state-trait anxiety inventory. Palo Alto, CA: Consulting Psychologists
Press, 1983.
42. Lazzari R, Pancheri P. S.T.A.I. Questionario di autovalutazione
dell’ansia di stato e di tratto. Firenze, Italy: Organizzazioni Speciali,
1980.
43. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a
brief depression severity measure. J Gen Intern Med
2001;16:606–13.
44. Kroenke K, Streine TW, Spitzer RL, et al. The PHQ-8 as a measure
of current depression in general population. J Affect Disord
2009;114:163–73.
45. Thekkumpurath P, Walker J, Butcher I, et al. Screening for major
depression in cancer outpatients: the diagnostic accuracy of the
9-item patient health questionnaire. Cancer 2011;117:218–27.
46. Politi PL, Piccinelli M, Wilkinson G. Reliability, validity and factor
structure of the 12-item general health questionnaire among young
males in Italy. Acta Psychiatr Scand 1994;90:432–7.
47. Eysenck SBG, Eysenck HJ, Barrett P. A revised version of the
psychoticism scale. Pers Individual Differences 1985;6:21–9.
48. O’Connor AM. User manual-decision self-efficacy scale. Patient
Decision Aids, Ottawa Hospital Research Institute (OHIR) Web site.
http://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_Decision_
SelfEfficacy.pdf (accessed 24 Octo 2012).
49. De Monchy C, Richardson R, Brown RA, et al. Measuring
attitudes of doctors: the doctor-patient (DP) rating. Med Educ
1988;22:231–9.
50. StataCorp. Stata Statistical Software: Release 11.2. College Station,
TX: StataCorp LP, 2011.
51. Pocock SJ. Clinical trials: a practical approach. New York: John
Wiley & Sons, 1983.
52. Sullivan LM, D’Agostino RB. Robustness and power of analysis of
covariance applied to ordinal scaled data as arising in randomized
controlled trials. Stat Med 2003;22:1317–34.
53. Little R, Yau L. Intent-to-treat analysis for longitudinal studies with
drop-outs. Biometrics 1996;52:1324–33.
54. Skrondal A, Rabe-Hesketh S. Generalized latent variable modelling:
multilevel, longitudinal, and structural equation models. New York:
Chapman & Hall/CRC, 2004.
55. Tattersall MHN, Butow PN. Consultation audio tapes: an underused
cancer patient information aid and clinical research tool. Lancet
Oncol 2002;3:431–7.
10 Goss C, Ghilardi A, Deledda G, et al. BMJ Open 2013;3:e002266. doi:10.1136/bmjopen-2012-002266
The INCA study protocol
 group.bmj.com on September 11, 2013 - Published by bmjopen.bmj.comDownloaded from 
doi: 10.1136/bmjopen-2012-002266
 2013 3: BMJ Open
 
Claudia Goss, Alberto Ghilardi, Giuseppe Deledda, et al.
 
INCA study protocol
the−−multicentre randomised controlled trial
during oncological consultations: a 
INvolvement of breast CAncer patients
 http://bmjopen.bmj.com/content/3/5/e002266.full.html
Updated information and services can be found at: 
These include:
References
 http://bmjopen.bmj.com/content/3/5/e002266.full.html#ref-list-1
This article cites 45 articles, 9 of which can be accessed free at:
Open Access
http://creativecommons.org/licenses/by-nc/3.0/legalcode
http://creativecommons.org/licenses/by-nc/3.0/ and 
compliance with the license. See:
work is properly cited, the use is non commercial and is otherwise in 
use, distribution, and reproduction in any medium, provided the original
Creative Commons Attribution Non-commercial License, which permits 
This is an open-access article distributed under the terms of the
service
Email alerting
the box at the top right corner of the online article.
Receive free email alerts when new articles cite this article. Sign up in
Collections
Topic
 (80 articles)Patient-centred medicine   
 (100 articles)Oncology   
 
Articles on similar topics can be found in the following collections
Notes
 http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
 http://journals.bmj.com/cgi/reprintform
To order reprints go to:
 http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
 group.bmj.com on September 11, 2013 - Published by bmjopen.bmj.comDownloaded from 
